IL-6 is upregulated in several cancers (breast, colorectal, ovarian, lung, and pancreas cancers) in both the tumor tissue and in the patient’s serum and is often associated with advanced disease and poor prognosis [160]. This evidence concerns the gene IL6 and neoplasm.